Long-term postmenopausal hormone substitution and incidence of breast cancer: the Nurses' Health Study
Hamerlynck, J.V.; van Leeuwen, F.E.
Nederlands Tijdschrift Voor Geneeskunde 140(14): 759-761
1996
ISSN/ISBN: 0028-2162 PMID: 8668260 Document Number: 467536
Document emailed within 1 workday
Related Documents
Wildemeersch, D. 2016: Safety and comfort of long-term continuous combined transdermal estrogen and intrauterine levonorgestrel administration for postmenopausal hormone substitution - a review Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 32(8): 598-601De Aloysio, D.; Mauloni, M.; Altieri, P.; Cappi, G.P.; Monterubbianesi, M.; Bottiglioni, F. 1992: Italian multicenter study for the verification of the efficacy and tolerability of short-term substitution hormone therapy using conjugated estrogens and progestagens administered orally in the postmenopausal a period Minerva Ginecologica 44(12): 629-639
Mannes, P.; Derriks, R.; Moens, R. 1972: Study of long-term survivors after treatment of thoracic metastases from breast cancer by hormone therapy and nonhormonal antineoplastic chemotherapy combined from the onset Revue de Tuberculose et de Pneumologie 36(3): 460-464
1988: Long-term breast feeding linked to lower incidence of breast cancer among Chinese women Oncology 2(11): 23
Taguchi, T.; Koyama, H.; Yayoi, K.; Wada, T.; Takatsuka, Y.; Sonoo, H.; Morimoto, K.; Tominaga, T.; Abe, R.; Enomoto, K. 1995: Long-term clinical study on TAP-144-SR, an LH-RH agonist depot formulation, in premenopausal patients with advanced or recurrent breast cancer. TAP-144-SR Breast Cancer Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(4): 495-508
Lippman, M.; Bolan, G.; Huff, K. 1976: The effects of glucocorticoids and progesterone on hormone-responsive human breast cancer in long-term tissue culture Cancer Research 36(12): 4602-4609
Ciammella, M.; Guareschi, B.; Pes, S.; Cocucci, C.; Nencioni, T. 1993: Substitution estrogen therapy in the prevention of postmenopausal osteoporosis and cardiovascular diseases. Results of long-term therapy Minerva Ginecologica 45(1-2): 53-55
Rageth, J.C.; Birkhäuser, M.; Castiglione, M. 1998: Hormone substitution therapy after breast cancer--a reevaluation Schweizerische Medizinische Wochenschrift 128(26): 1037-1042
Chen, F.-P. 2009: Postmenopausal hormone therapy and risk of breast cancer Chang Gung Medical Journal 32(2): 140-147
Chen, F.P.; Lee, N.; Soong, Y.K.; Huang, K.E. 2001: Short- and long-term effects of hormone replacement therapy on cardiovascular risk factors in postmenopausal women Chang Gung Medical Journal 24(7): 431-439
Inafuku, K.; Inari, H.; Goto, N.; Kawamoto, M.; Hatori, S.; Tanabe, H.; Masuda, M. 2014: A case of postmenopausal breast cancer becoming HER2 positive after neoadjuvant hormone therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(4): 487-489
Vavilis, D.; Zafrakas, M.; Goulis, D.G.; Pantazis, K.; Agorastos, T.; Bontis, J.N. 2009: Hormone therapy for postmenopausal breast cancer survivors: a survey among obstetrician-gynaecologists European Journal of Gynaecological Oncology 30(1): 82-84
Hu, L.; Yue, Y.; Zuo, P.-P.; Jin, Z.-Y.; Feng, F.; You, H.; Li, M.-L.; Ge, Q.-S. 2006: Evaluation of neuroprotective effects of long-term low dose hormone replacement therapy on postmenopausal women brain hippocampus using magnetic resonance scanner Chinese Medical Sciences Journal 21(4): 214-218
Novoa Vargas, A.; Font López, K.C.; Amador, D.D. 2011: Letrozole vs. tamoxifen as neoadjuvant therapy for postmenopausal patients with hormone-dependent locally-advanced breast cancer Ginecologia y Obstetricia de Mexico 79(9): 553-557
Klaassen, D.J.; Rapp, E.F.; Hirte, W.E. 1976: Response to medroxyprogesterone acetate (NSC-26386) as secondary hormone therapy for metastatic breast cancer in postmenopausal women Cancer Treatment Reports 60(3): 251-253
Sattin, R W.; Rubin, G L.; Wingo, P A.; Webster, L A.; Ory, H W. 1987: Oral-Contraceptive Use and the Risk of Breast Cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development Obstetric and Gynecologic Survey 42(2): 120-121
Gass, R.; Neff, M. 1995: Prevention of postmenopausal osteoporosis: how effective is transdermal hormone substitution? (Continuous estradiol plus sequential oral norethisterone acetate) Schweizerische Medizinische Wochenschrift 125(34): 1583-1591
Schouten, L.J.; de Rijke, J.M.; Schlangen, J.T.; Verbeek, A.L. 1997: Hormone replacement therapy and high incidence of breast cancer between mammographic screens Lancet 349(9058): 1104
Breckwoldt, M.; Keck, C. 1994: Hormone substitution beginning when, with what, how long? Geburtshilfe und Frauenheilkunde 54(5): M67-M69
Stjernquist, M. 2003: After the early termination of the Women's Health Initiative study. New American recommendations for postmenopausal hormone therapy Lakartidningen 100(20): 1790-1797